Introduction
Insulin plays a key role in the stimulation of glucose uptake in muscle and adipose tissues. Type 2 diabetes occurs when insulin is unable to stimulate glucose uptake in the tissues. Insulin-stimulated glucose uptake and metabolism is one of the fundamental mechanisms responsible for the maintenance of glucose homeostasis in the body [28]. Insulin maintains glucose homeostasis by promoting glucose uptake into muscle and adipose tissues. Insulin-mediated glucose uptake involves a series of signaling cascades initiated by insulin binding to its receptor on the cell surface [10]. Glucose uptake in response to insulin in muscle and adipose tissues is mediated by glucose transporter 4 (GLUT4). The mechanism of insulin-stimulated glucose uptake is through the translocation of GLUT4 from intracellular storage sites to the plasma membrane (PM). Insulin initiates the signaling pathway by activating the insulin receptor, leading to the phosphorylation of insulin receptor substrate (IRS) and subsequently, activating phosphatidylinositol-3-kinases (PI3K) that mediates protein kinase B (PKB; AKT) phosphorylation by generating phosphatidylinositol-3, 4, 5-trisphosphate. The phosphorylated AKT stimulates downstream signaling and finally, stimulates glucose uptake by translocating GLUT4 from intracellular vesicles to the PM [12,20].
Ecklonia cava (E. cava) is a brown alga found mainly in the pacific ocean off Japan and Korea. E. cava exerts various biological activities such as antioxidant activity [14], an- ti-HIV activity [1], anticancer activity [19] and antiallergic effect [29]. In a recent study, dieckol, which is phlorotannin from Ecklonia cava increased insulin sensitivity by stimulating phosphorylation of IRS-1 and Akt [13,17]. 2, 7-phlor-oglucinol-6, 6-bieckol (PHB) isolated from Ecklonia cava, is newly known substances but only antioxidative effects are known [16]. Thus, in the present study, we investigated its effects on glucose uptake through the regulation of insulin signaling pathway in 3T3-L1 cells.
Materials and Methods
Isolation of PHB from E. cava extract
The isolation and purification of PHB from the 70% EtOH extract of E. cava were performed by using a previously described method [21]. The product isolated was confirmed as PHB by LC–DAD–ESI-MS and 1D NMR spectrum. After purification, its 1H-NMR and 13C-NMR spectra were obtained on a JEOL JNM-LA 300 spectrometer (JEOL Ltd., Tokyo, Japan). FAB-MS and ESI-MS profiles were recorded on a JEOL JMS 700 spectrometer. PHB: amorphous powder, 1H NMR (400 MHz, MeOH-d6) d 5.57 (1H, s), 5.89 (1H, s), 5.74 (1H, m), 5.84 (1H, m), 5.74 (1H, m), 6.25 (1H, s), 6.14 (1H, s), 5.84 (1H, m), 5.89 (1H, m), 5.84 (1H, m), 6.52 (1H, s), 6.14 (1H, m), 6.44 (1H, m), 6.77 (1H, s), 6.72 (1H, s), 8.93 (1H, s), 8.93 (1H, s), 9.19 (1H, s), 9.19 (1H, s), 9.19 (1H, s), 9.04 (1H, s), 8.26 (1H, s), 9.94 (1H, s), 8.59 (1H, s), 9.88 (1H, s), 9.86 (1H, s), 9.25 (1H, s), 9.75 (1H, s), 9.21 (1H, s) ; 13C NMR (400 MHz, MeOH-d6) d 127.6, 143.0, 93.0, 137.1, 125.6, 147.2, 106.5, 152.2, 95.5, 152.4, 127.6, 137.1, 162.0, 98.7, 160.3, 95.5, 160.3, 98.8, 124.3, 147.2, 94.5, 144.1, 124.3, 147.2, 110.0, 144.1, 101.5, 151.8, 137.2, 144.1, 159.7, 96.7, 157.1, 95.5, 157.1, 96.7, 159.8, 97.8, 159.3, 95.2, 159.2, 97.9, 122.5, 153.9, 99.8, 156.8, 99.9, 152.8 (d) ; ESI-MS: [M-H]- at m/z 973.37 [22].
Cell culture and adipocyte differentiation
Mouse 3T3-L1 preadipocytes were purchased from Korean Cell Line Bank (KCLB, Seoul, Korea) and were grown in high glucose (4.5 mM) DMEM with 10% FBS at 37℃ in 5% CO2 atmosphere. These cells were induced to differentiate into adipocytes as described. Briefly, 2 days after confluence, the medium was changed to 10% FCS DMEM supplemented with 0.5 mM isobutylmethylxanthine, 1 μM dexamethasone, and 10 μg/ml insulin. Subsequently, cells were treated with 10 μg/ml insulin in 10% FCS DMEM for an additional 24 hr and then maintained with 10% FCS with the media being replaced every other day for 8 days. With this protocol, more than 80% of the preadipocytes differentiated into adipocytes [9].
2-Deoxy glucose uptake assay
Glucose uptake assay using a 2-(N-(7-nitrobenz-2-oxa-1, 3- diazol-4-yl)amino)-2 deoxyglucose (2-NBDG) screening system was measured as previously described with some modifications [30]. Briefly, differentiated 3T3-L1 adipocytes were seeded with indicated concentrations of PHB for 24 hr at 1×104 cells per well into 96-well plates. After incubation, cells were left untreated or stimulated with 100 nM insulin for 20 min at 37℃ in Kreb’s ringer phosphate buffer (128 mM NaCl, 4.7 mM KCl, 1.25 mM CaCl2, 1.25 mM MgSO4, and 10 mM NaPO4; pH 7.4). Glucose uptake was initiated by the addition of 80 μM 2-NBDG to each well. After 1 hr, the supernatant was removed. 2-NBDG uptake was measured by a Multilabel Counter (Perkin Elmer, MA, USA) set at an excitation wavelength of 485 nm and an emission wavelength of 535 nm.
Western blot analysis
This assay was performed using a modified version of a protocol previously described [8]. For extracting total proteins from adipocytes, the cells were washed twice with ice-cold PBS and harvested in a lysis buffer (RIPA, 50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 1 mM PMSF, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 0.1 mM sodium orthovanadate; pH 7.4). After sonication and centrifugation at 13, 000 ×g for 30 min at 4℃, the protein content of the resulting supernatant was determined using a BCA protein assay kit. The lysate containing 20 μg of protein was subjected to 10% SDS-PAGE. Separated proteins were electroblotted on a pure nitrocellulose membrane, blocked with 5% skim milk for 1 hr, and then incubated with primary antibodies (Abcam, Cambridge, UK; 1:1, 000) overnight at 4℃. After washing, the blots were incubated with goat anti-rabbit or goat anti-mouse IgG HRP-conjugated secondary antibody for 1 hr at room temperature. Each antigen-antibody complex was visualized using ECL Western Blotting Detection Reagents and detected by chemiluminescence with LAS-1000 plus (FUJIFILM, Tokyo, Japan). Band densities were determined by an image analyzer (Multi-Gauge V3.1, FUJIFILM Corporation, Valhalla, NY, USA) and normalized to β-actin for total protein and nuclear protein.
Isolation of PMs from 3T3-L1 adipocytes
Isolation of plasm membrane was performed as described with some modification [18]. 3T3-L1 adipocytes were homogenized by sonication for 5 min at 3 kHz/130 W (UCD- 130TM, Cosmo Bio Co., Tokyo, Japan) in ice-cold HES buffer (0.02 M HEPES, 0.25 M sucrose, and 2 mM EGTA; pH 7.4) and centrifuged at 700×g for 7 min to remove unhomogenized cellular debris and nuclei from the homogenate. The harvested supernatant was further centrifuged at 760 ×g for 10 min to remove mitochondria. After recentrifuging at 35, 000 ×g for 60 min, the resulting pellet was used as the PM fraction of the adipocytes. The supernatant was used as the cytosol fraction. These fractions were subjected to western blotting to detect GLUT4 levels. The amounts of protein in these fractions were quantified by using a BCA protein assay kit.
Statistical analysis
Each experiment was performed in triplicate. The results were expressed as the mean ± SD. Statistical analyses were performed using SPSS software (SPSS version 13.0, USA). Statistical significance was determined by the Student’s t-test.
Results
Effect of PHB on 2-deoxy glucose uptake
To establish the effect of PHB on glucose uptake, we evaluated its effects on 2-deoxy glucose uptake in differentiated 3T3-L1 adipocytes. Incubation of cells with PHB stimulated glucose uptake in dose-dependent manner. PHB exerted an initial significant effect on glucose uptake at 5 μM and a maximal effect at 50 μM (p<0.05; Fig. 1). PHB significantly increased glucose uptake by 1.13, 1.28, 1.63, and 1.91 fold at 5, 10, 25, and 50 μM, ((p<0.05; Fig. 1). These results indicate that PHB enhances glucose uptake in 3T3-L1 adipocytes.
Fig. 1. Effect of 2, 7-phloroglucinol-6, 6-bieckol on glucose uptake in 3T3-L1 adipocytes. Differentiated 3T3-L1 adipocytes were treated with various concentrations of 2, 7-phlor-oglucinol-6, 6-bieckol (PHB) for 2 hr before 2-deoxy glucose uptake measurement. Each value is expressed as mean±s.d. in triplicate experiments. a-dValues with different alphabets are significantly different at p<0.05 as analyzed by Duncan's multiple range test.
Effect of PHB on PI3K/AKT pathway signaling
To evaluate the mechanism of PHB-induced glucose up-take, we measured the expression of IRS-1, PI3K, and AKT. Results shown in Fig. 2 demonstrate that PHB significantly increases the phosphorylation of IRS-1 and activation of IRS-1. At 50 μM, PHB increased the phosphorylation of IRS-1 to 173.3% of control, respectively. We also determined the activation of phosphorylation of Akt. As expected, insulin stimulation resulted in augmentation of phosphorylation of Akt. PHB also increased the phosphorylation. In regards to enhancement of Akt phosphorylation, PHB was almost potent as insulin. The activation of PI3K is necessary for insulin-stimulated glucose uptake. We examined the activation of PI3K on PHB-stimulated glucose uptake. PI3K activation was remarkably enhanced by PHB. Treatment with 10 and 50 μM of PHB increased PI3K activation to 134.5% and 151.2% of control, respectively. These results suggested that glucose uptake by PHB is possibly mediated via a PI3K-Akt pathway.
Fig. 2. Effects of 2, 7-phloroglucinol-6, 6-bieckol on insulin signaling in 3T3-L1 adipocytes. Differentiated adipocytes were incubated with 10 or 50 μM 2, 7-phloroglucinol-6, 6-bieckol or 100 nM insulin for 2 hr, and then, the cells were extracted and subjected to immunoblot analysis. (A) phosphorylation level of insulin receptor substrate-1 (IRS1). (B) Phosphorylation level of AKT. (C) Expression levels of PI3K. Each value is expressed as mean±s.d. in triplicate experiments. a-dValues with different alphabets are significantly different at p<0.05 as analyzed by Duncan's multiple range test.
Effect of PHB on 5' AMP-activated protein kinase (AMPK) activation
We investigated the effects of PHB on AMPK activation by western blotting. As shown in Fig. 3, PHB stimulated AMPK phosphorylation to 126.3% and 157.6% of control at PHB concentrations of 10 and 50 μM, respectively. Insulin did not significantly increase AMPK phosphorylation (p< 0.05, Fig. 3). To examine whether the PHB stimulation of glucose uptake was mediated by AMPK activation, we pretreated the cells with compound C (10 μM). Compound C markedly decreased AMPK phosporylation to 20.05% and 28.34% in the presence of 10 and 50 μM PHB, respectively (Fig. 3). These results indicated phosphorylation of AMPK might play an important role in the PHB mechanism of stimulation of glucose uptake.
Fig. 3. Effects of 2, 7-phloroglucinol-6, 6-bieckol on AMPK expression in 3T3-L1 adipocytes. Differentiated adipocytes were incubated with 10 or 50 μM 2, 7-phloroglucinol-6, 6- bieckol (PHB) or 100 nM insulin for 2 hr or in combination with 10 μM compound C (CC) and then, the cells were extracted and subjected to immunoblot analysis. Each value is expressed as mean±s.d. in triplicate experiments. a-cValues with different alphabets are significantly different at p<0.05 as analyzed by Duncan's multiple range test.
Effect of PHB on PM-GLUT4 expression
To investigate the effect of PHB on PM-GLUT4 expression, the differentiated adipocytes were fractionated and subjected to immunoblotting. Fig. 4 shows that PHB significantly increased the expression of PM-GLUT4 to 348% of control. To elucidate the signaling pathways involved in PHB-mediated activity, the effect of PHB on GLUT 4 activation was analyzed in the presence of specific inhibitors for PI3K (wortmannin) and AMPK (compound C). Pretreatment of adipocytes with wortmannin, or compound C markedly decreased the PM-GLUT4 expression induced by PHB (Fig. 4). As shown in FIG. 4, when compared with the level of PM-GLUT4 treated with PHB alone, wortmannin was inhibited to 156% and compound C was inhibited to 173%. These results imply that PHB stimulated glucose uptake and enhances PM-GLUT4 expression by activating the PI3K/ AKT and AMPK pathways in 3T3-L1 adipocytes.
Fig. 4. Effects of 2, 7-phloroglucinol-6, 6-bieckol on GLUT4 protein expression in 3T3-L1 adipocytes. Differentiated adipocytes were incubated with 50 μM 2, 7-phloroglucinol-6, 6-bieckol (PHB) or 100 nM insulin for 2 hr or with PHB in combination with 10 μM compound C (CC) or 20 μM wortmannin (WM) and then, the cells were extracted and subjected to immunoblot analysis. Each value is expressed as mean±s.d. in triplicate experiments. a-dValues with different alphabets are significantly different at p<0.05 as analyzed by Duncan's multiple range test.
Discussion
PHB isolated from E. cava has been known to have antioxidant properties, but its effect on glucose uptake has not been confirmed. Thus, this study investigated the effect of PHB on glucose uptake in 3T3-L1 adipocytes and the underlying cellular mechanism.
Glucose homeostasis is determined by glucose production and utilization in insulin-sensitive organs and tissues, including the muscle, liver, and adipose tissue [11]. Glucose uptake in the adipose tissue plays a critical role in glucose homeostasis. Insulin stimulates glucose uptake by binding to the insulin receptor at the cell surface, leading to the activation of GLUT4 [24]. In this study, PHB significantly enhanced glucose uptake in 3T3-L1 adipocytes. The mechanism of glucose uptake in adipocytes is generally associated with PI3K/AKT and AMPK pathways [23,25]. Among the two mechanisms, the PI3K/AKT pathway is crucial in mediating the hypoglycemic effect of insulin through IRS activation. The AMPK pathway also activates GLUT4 translocation to the PM, which increases intracellular glucose uptake [5].
To identify the mechanism of the PHB-stimulated increase in glucose uptake, we investigated the activation of PI3K/ AKT and AMPK pathways. In the present study, treatment with PHB in 3T3-L1 adipocytes markedly increased the phosphorylation of IRS-1 and AKT. Additionally, PHB increased PI3K activation, which is important for GLUT4 activation. In the PI3K/AKT signaling cascade for glucose uptake, the activation of insulin receptor β subunit results in the subsequent phosphorylation of the downstream signaling molecule, IRS-1. Phosphorylated IRS-1 activates PI3K formation, which stimulates the phosphorylation of its downstream effector, AKT. AKT phosphorylation then induces the translocation of GLUT4 from the cytoplasm to the PM, which promotes the uptake of glucose into the cell [2, 7, 26]. In addition to the PI3K pathway, AMPK signaling influences GLUT4 translocation and glucose uptake in muscles and adipocytes [4]. In this study, PHB increased p-AMPK level, and compound C (AMPK inhibitor) suppressed this PHB-mediated increase in p-AMPK level. Therefore, PHB seemed to increase glucose uptake by activating PI3K/AKT and AMPK pathways. Its effect on PI3K/AKT signaling was greater than that on AMPK signaling. Therefore, it could be considered that glucose uptake by PHB occurs mainly through the PI3K/AKT pathway.
To support these findings, we further investigated the effect of specific inhibitors on PM-GLUT4 expression. GLUT4 plays a major role in regulating glucose transport in muscles and adipocytes. GLUT4 translocation to the PM is triggered by the insulin receptor, followed by the activation of various protein kinases involved in the PI3K/AKT pathway [6]. Moreover, GLUT4 translocation is triggered by AMPK, which increases glucose uptake by cells [27]. In experiments using inhibitors, PHB-mediated increased in PM-GLUT4 expression was suppressed by both wortmannin (PI3K inhibitor) and compound C (AMPK inhibitor). The effect was significant when the PI3K inhibitor was used, indicating that the increase in glucose uptake by PHB mainly occurs by PI3K/AKT pathway activation.
PHB is a type of marine algal polyphenols (phlorotannins) isolated from E. cava, a brown alga. Polyphenols have been reported to exert insulin-like effects in vivo and in vitro [12, 14, 31]. Insulin generally acts via two major signaling path- ways. One is the mitogen-activated protein kinase (MAPK) pathway and the other is the PI3K/AKT pathway. Among the two mechanisms, the PI3K/AKT pathway is important in mediating the hypoglycemic effect of insulin [3]. The poly- phenol-rich extract of E. cava is reported to activate insulin signaling pathways i.e., increase AKT and AMPK phosphorylation and activation; particularly, the ratio of p-AKT/AKT after treatment with the extract was comparable to that after insulin treatment in this report [15]. Taken together, PHB appears to increase glucose uptake by activating PI3K/AKT and AMPK pathways and translocating GLUT4 from the cytoplasm to the PM.
In conclusion, PHB enhances glucose uptake by activating the PI3K/AKT pathway, IRS-1 phosphorylation, and the AMPK pathway in 3T3-L1 adipocytes. The phosphorylation and activation of PI3K/AKT and AMPK pathways by PHB were confirmed using wortmannin (PI3K inhibitor) and compound C (AMPK inhibitor); these inhibitors inhibited PHB-induced PM-GLUT4 expression. These results suggest that PHB may help to improve insulin sensitivity.
Acknowledgment
This work was supported by a 2-year research grant of Pusan National University.
The Conflict of Interest Statement
The authors declare that they have no conflicts of interest with the contents of this article.
References
- Artan, M., Li, Y., Karadeniz, F., Lee, S. H., Kim, M. M. and Kim, S. K. 2008. Anti-HIV-1 activity of phloroglucinol derivative, 6,6-bieckol, from Ecklonia cava. Bioorg. Med. Chem. 16, 7921-7926. https://doi.org/10.1016/j.bmc.2008.07.078
- Carvalho, E., Jansson, P. A., Nagaev, I., Wenthzel, A. M. and Smith, U. 2001. Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport. FASEB. J. 15, 1101-1103. https://doi.org/10.1096/fsb2fj000435fje
- Conejo, R, Valverde, A. M, Benito, M. and Lorenzo, M. 2001. Insulin produces myogenesis in C2C12 myoblasts by induction of NF-κB and downregulation of AP-1 activities. J. Cell Physiol. 186, 82-94. https://doi.org/10.1002/1097-4652(200101)186:1<82::AID-JCP1001>3.0.CO;2-R
- Cool, B., Zinker, B., Chiou, W., Kifle, L., Cao, N., Perham, M., Dickinson, R., Adler, A., Gagne, G., Iyengar, R., Zhao, G., Marsh, K., Kym, P., Jung, P., Camp, H. S. and Frevert, E. 2006. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab. 3, 403-416. https://doi.org/10.1016/j.cmet.2006.05.005
- Czech, M. P. and Corvera, S. 1999. Signaling mechanisms that regulate glucose transport. J. Biol. Chem. 274, 1865-1868. https://doi.org/10.1074/jbc.274.4.1865
- Ducluzeau, P. H., Fletcher, L. M., Vidal, H., Laville, M. and Tavare, J. M. 2002. Molecular mechanisms of insulin-stimulated glucose uptake in adipocytes. Diabetes Metab. 28, 85-92.
- Elmendorf, J. S., Damrau-Abney, A., Smith, T. R., David, T. S. and Turinsky, J. 1995. Insulin stimulated phosphatidylinositol 3-kinase activity and 2-deoxy-D-glucose uptake in rat skeletal muscles. Biochem. Biophys. Res. Commun. 28, 1147-1153.
- Fido, R. J., Tatham, A. S. and Shewry, P. R. 1995. Western blotting analysis. Plant Gene Transfer and Expression Protocols 49, 423-437. https://doi.org/10.1385/0-89603-321-X:423
- Green, H. and Kehinde, O. 1974. Sublines of mouse 3T3 cells that accumulate lipid. Cell 1, 113-116. https://doi.org/10.1016/0092-8674(74)90126-3
- Herman, M. A. and B Kahn, B. B. 2006. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J. Clin. Invest. 116, 1767-1775. https://doi.org/10.1172/JCI29027
- Hers, H. G. 1990. Mechanisms of blood glucose homeostasis. J. Inherit. Metab. Dis. 13, 395-410. https://doi.org/10.1007/BF01799497
- Holman, G. D. and Kasuga, M. 1997. From receptor to transporter: insulin signaling to glucose transport. Diabetologia 40, 991-1003. https://doi.org/10.1007/s001250050780
- Jeon, H. J., Yoon, K. Y., Koh, E. J., Choi, J., Kim, K. J., Choi, H. S. and Lee, B. Y. 2015. Seapolynol and dieckol improve insulin sensitivity through the regulation of the PI3K pathway in C57BL/KsJ-db/db mice. J. Food Nutr. Res. 3, 648-652. https://doi.org/10.12691/jfnr-3-10-5
- Kang, K.,A., Lee, K. H., Chae, S. W., Zhang, R., Jung, M. S., Lee, Y. K., Kim, S. Y., Kim, H. S., Joo, H. G., Park, J. W., Ham, Y. M., Lee, N. H. and Hyun, J. W. 2005. Eckol isolated from Ecklonia cava attenuates oxidative stress induced cell damage in lung fibroblast cells. FEBS. Lett. 579, 6295-6304. https://doi.org/10.1016/j.febslet.2005.10.008
- Kang, C. K., Jin, Y. B., Lee, H. K., Cha, M. J., Sohn, E. T., Moon, J. H., Park, C. W., Chun, S. H., Jung, E. S., Hong, J. S., Kim, S. B., Kim, J. S. and Kim, E. K. 2010. Brown alga Ecklonia cava attenuates type 1 diabetes by activating AMPK and Akt signaling pathways. Food Chem. Toxicol. 48, 509-516. https://doi.org/10.1016/j.fct.2009.11.004
- Kang, S. M., Heo, S. J., Kim, K. N., Lee, S. H. and Jeon, Y. J. 2012. Isolation and identification of new compound, 2, 7"-phloroglucinol-6, 6'-bieckol from brown algae, Ecklonia cava and its antioxidant effect. J. Funct. Foods 4, 158-166. https://doi.org/10.1016/j.jff.2011.10.001
- Kang, M. C., Wijesinghe, W. A. J. P., Lee, S. H., Kang, S. M., Ko, S. C., Yang, X., Kang, N. L, Jeon, B. T, Kim, J. I., Lee, D. H. and Jeon, Y. J. 2013. Dieckol isolated from brown seaweed Ecklonia cava attenuates type II diabetes in db/db mouse model. Food Chem. Toxicol. 53, 294-298. https://doi.org/10.1016/j.fct.2012.12.012
- Kohn, A. D., Summers, S. A., Birnbaum, M. J. and Roth, R. A. 1996. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem. 271, 31372-31378. https://doi.org/10.1074/jbc.271.49.31372
- Kong, C. S., Kim, J. A., Yoon, N. Y. and Kim, S. K. 2009. Induction of apoptosis by phloroglucinol derivative from Ecklonia cava in MCF-7 human breast cancer cells. Food Chem. Toxicol. 47, 1653-1658. https://doi.org/10.1016/j.fct.2009.04.013
- Krook, A., Wallberg-Henriksson, H. and Zierath, J. R. 2004. Sending the signal: molecular mechanisms regulating glucose uptake. Med. Sci. Sports Exerc. 36, 1212-1217. https://doi.org/10.1249/01.MSS.0000132387.25853.3B
- Lee, J. Y., Ko, J. Y., Oh, J. Y., Kim, C. Y., Lee, H. J., Kim, J. I. and Jeon, Y. J. 2014. Preparative isolation and purification of phlorotannins from Ecklonia cava using centrifugal partition chromatography by one step. Food Chem. 1, 433-437.
- Lee, H. A., Lee, J. H. and Han, J. S. 2018. 2,7"-Phloroglucinol-6,6'-bieckol protects INS-1 cells against high glucose-induced apoptosis. Biomed. Pharmacother. 103, 1473-1481. https://doi.org/10.1016/j.biopha.2018.04.129
- Musi, N. 2006. AMP-activated protein kinase and type 2 diabetes. Curr. Med. Chem. 13, 583-589. https://doi.org/10.2174/092986706776055724
- Piper, R. C., Hess, L. J. and James, D. E. 1991. Differential sorting of two glucose transporters expressed in insulin-sensitive cells. Am. J. Physiol. 260, 570-580.
- Ramachandran, V. and Saravanan, R. 2015. Glucose uptake through translocation and activation of GLUT4 in PI3K/Akt signaling pathway by asiatic acid in diabetic rats. Hum. Exp. Toxicol. 34, 884-893. https://doi.org/10.1177/0960327114561663
- Rosen, E. D. and Spiegelman, B. M. 2006. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847-853. https://doi.org/10.1038/nature05483
- Salt, I. P., Connell, J. M. and Gould, G. W. 2000. 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. Diabetes 49, 1649-1656. https://doi.org/10.2337/diabetes.49.10.1649
- Saltiel, A. R. and Kahn, C. R. 2001. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414, 799-806. https://doi.org/10.1038/414799a
- Shim, S. Y., Quang-To, L., Lee, S. H. and Kim, S. K. 2009. Ecklonia cava extract suppresses the high affinity IgE receptor, FcRI expression. Food Chem. Toxicol. 47, 555-560. https://doi.org/10.1016/j.fct.2008.12.012
- Thomson, M. J., Williams, M. G. and Frost, S. C. 1997. Development of insulin resistance in 3T3-L1 adipocytes. J. Biol. Chem. 272, 7759-7764. https://doi.org/10.1074/jbc.272.12.7759
- Zhang, J., Tiller, C., Shen, J., Wang, C., Girouard, G. S., Dennis, D., Barrow, C. J., Miao, M. and Ewart, H. S. 2007. Antidiabetic properties of polysaccharide- and polyphenol-enriched fractions from the brown seaweed Ascophyllum nodosum. Can. J. Physiol. Pharmacol. 85, 1116-1123. https://doi.org/10.1139/Y07-105